Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
35 studies found for:    " October 13, 2010":" November 12, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Completed Young Women's CoOp Study
Conditions: HIV;   Sexual Risk;   Sexually Transmitted Diseases;   Substance Abuse;   Violence;   Victimization
Interventions: Behavioral: Young Women's CoOp;   Behavioral: Staying Healthy and Eating Well
22 Completed IMPAACT P1073: Study of IRIS for Infants and Children Initiating HAART at Int'l Sites
Conditions: IRIS;   HIV
Intervention:
23 Recruiting IMPAACT P1080: Psychiatric and Antiretroviral Medication Concentrations in HIV-infected and Uninfected Children and Adolescents
Conditions: ADHD;   HIV
Intervention:
24 Completed Study Targeting Affect Regulation
Conditions: HIV;   AIDS;   Substance Use Disorders
Intervention: Behavioral: Resilient Affective Processing Therapy (RAPT)
25 Completed Prevention of HIV and STDs in Drug Using Women
Conditions: HIV;   Sexually Transmitted Diseases;   Substance Abuse
Interventions: Behavioral: NIDA Cooperative Agreement Standard Intervention plus HIV/STD testing;   Behavioral: Standard Intervention plus Well-Woman Exam;   Behavioral: Standard Intervention plus Well-Woman Exam and Peer-Delivered Intervention
26 Completed Multi-vitamins, HAART and HIV/AIDS in Uganda
Condition: HIV/AIDS
Intervention: Dietary Supplement: Multivitamin supplements B,C and E
27 Unknown  Effect of Maraviroc (MCV) on the Immunological Recovery of HIV-1 Discordant Patients With CD4 Lymphocyte Counts Below 200 Cells/mm3
Condition: HIV-1 Infection
Intervention: Drug: Maraviroc
28 Recruiting Reducing Heavy Drinking to Optimize HIV/AIDS Treatment and Prevention
Condition: Reduction in Heavy Drinking in Patients With HIV
Interventions: Drug: Naltrexone;   Other: Placebo + Medication Management/Medication Coaching
29 Unknown  Safety Study of Raltegravir in HIV/HCV Co-infected Patients
Conditions: HIV;   Hepatitis C
Interventions: Drug: raltegravir;   Drug: Atazanavir/ritonavir
30 Active, not recruiting Effects of Cash Transfer for the Prevention of HIV in Young South African Women
Condition: HIV
Interventions: Behavioral: monthly cash transfer payments for attending school;   Behavioral: B--No cash transfers
31 Completed
Has Results
Effects of Famotidine on the Pharmacokinetics of Atazanavir When Coadministered to Participants With HIV Infection
Condition: HIV
Interventions: Drug: Atazanavir;   Drug: Ritonavir;   Drug: Tenofovir (TDF);   Drug: Nucleoside Reverse Transcriptase Inhibitor (NRTI);   Drug: Famotidine (FAM)
32 Completed Gentian Violet Vs. Nystatin Oral Suspension for Treatment of Oropharyngeal Candidiasis
Condition: HIV-1 Infection
Interventions: Drug: Gentian Violet;   Drug: Nystatin oral suspension
33 Active, not recruiting Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis & T-cells
Condition: HIV-1 Infection
Intervention: Drug: atorvastatin
34 Unknown  Preventing Health Damaging Behaviors in Male and Female Army Recruits
Conditions: Sexually Transmitted Infection (STI) Prevention;   Unintended Pregnancy Prevention;   Sexual Risk Reduction;   Alcohol and Other Substance Use Prevention;   Intimate Partner Violence Prevention
Intervention: Behavioral: Staying Safe & In Control: Increasing Knowledge and Building Skills to Prevent STIs and Unintended Pregnancy
35 Active, not recruiting Third Line Highly Active Antiretroviral Therapy (HAART) in HIV-infected Children
Condition: This Study is Designed to Collect Treatment Data of Thai Children on Third Line ARV Therapy.
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-35) Next Page   
Indicates status has not been verified in more than two years